Lipid advanced glycosylation: pathway for lipid oxidation in vivo.

Por Bucala, R, Makita, Z, Koschinsky, T, Cerami, A, Vlassara, H
Publicado em 1993

Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients.

Por Takeuchi, M., Makita, Z., Yanagisawa, K., Kameda, Y., Koike, T.
Publicado em 1999

Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.

Por Takeuchi, M., Makita, Z., Bucala, R., Suzuki, T., Koike, T., Kameda, Y.
Publicado em 2000

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.

Por Vlassara, H, Fuh, H, Makita, Z, Krungkrai, S, Cerami, A, Bucala, R
Publicado em 1992

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.

Por Bucala, R, Makita, Z, Vega, G, Grundy, S, Koschinsky, T, Cerami, A, Vlassara, H
Publicado em 1994

Immunological detection of a novel advanced glycation end-product.

Por Takeuchi, M., Yanase, Y., Matsuura, N., Yamagishi Si, S., Kameda, Y., Bucala, R., Makita, Z.
Publicado em 2001

Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus.

Por Nakamura, Y., Horii, Y., Nishino, T., Shiiki, H., Sakaguchi, Y., Kagoshima, T., Dohi, K., Makita, Z., Vlassara, H., Bucala, R.
Publicado em 1993